Aspiriant LLC’s Enbridge ENB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$294K Sell
5,437
-353
-6% -$18K 0.01% 278
2025
Q4
$277K Buy
5,790
+353
+6% +$16.9K 0.01% 286
2025
Q3
$274K Hold
5,437
0.01% 264
2025
Q2
$246K Hold
5,437
0.01% 282
2025
Q1
$241K Hold
5,437
0.01% 266
2024
Q4
$231K Hold
5,437
0.01% 265
2024
Q3
$221K Buy
+5,437
New +$209K 0.01% 268
2023
Q3
Sell
-5,437
Closed -$202K 287
2023
Q2
$202K Hold
5,437
0.01% 273
2023
Q1
$207K Hold
5,437
0.01% 266
2022
Q4
$213K Hold
5,437
0.01% 253
2022
Q3
$201K Sell
5,437
-140
-3% -$5.9K 0.01% 253
2022
Q2
$236K Sell
5,577
-1,689
-23% -$75.4K 0.01% 240
2022
Q1
$335K Hold
7,266
0.02% 214
2021
Q4
$283K Buy
+7,266
New +$291K 0.02% 233
2020
Q2
Sell
-7,238
Closed -$210K 184
2020
Q1
$210K Sell
7,238
-3,158
-30% -$117K 0.02% 175
2019
Q4
$414K Sell
10,396
-113
-1% -$4.22K 0.04% 151
2019
Q3
$370K Sell
10,509
-5,558
-35% -$192K 0.03% 165
2019
Q2
$581K Sell
16,067
-1,574
-9% -$57.3K 0.05% 139
2019
Q1
$641K Sell
17,641
-9,397
-35% -$339K 0.05% 133
2018
Q4
$844K Sell
27,038
-1,679
-6% -$54K 0.06% 116
2018
Q3
$929K Sell
28,717
-1,448
-5% -$50.6K 0.08% 112
2018
Q2
$1.08M Buy
30,165
+2,532
+9% +$80.2K 0.09% 104
2018
Q1
$870K Buy
+27,633
New +$967K 0.08% 115
2017
Q4
Sell
-32,872
Closed -$1.38M 110
2017
Q3
$1.38M Sell
32,872
-10,383
-24% -$422K 0.12% 92
2017
Q2
$1.72M Sell
43,255
-2,763
-6% -$111K 0.15% 82
2017
Q1
$1.93M Buy
+46,018
New +$1.94M 0.16% 85

Other funds holding ENB

Aspiriant LLC's ENB Position: Q1 2026 in Review

Aspiriant LLC reduced its Enbridge (ENB) stake by 6.1% in Q1 2026, selling an estimated $18K and leaving 5,437 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #278.

Aspiriant LLC first reported a position in ENB in Q1 2017 and has held it in 26 quarters since. The position peaked at $1.93M in Q1 2017. 1,497 funds tracked by Wall St. Rank hold ENB as of Q1 2026.

  • Aspiriant LLC held 5,437 shares of Enbridge worth $294K as of Q1 2026.
  • Aspiriant LLC sold 353 Enbridge shares in Q1 2026, an estimated $18K.
  • Enbridge made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #278 holding.
  • Aspiriant LLC first reported a position in Enbridge in Q1 2017 and has held it in 26 quarters since.
  • Aspiriant LLC's Enbridge position peaked at $1.93M in Q1 2017.
  • 1,497 funds tracked by Wall St. Rank held Enbridge as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.